Potential trends in Attention Deficit Hyperactivity Disorder (ADHD) drug use on a college campus: Wastewater analysis of amphetamine and ritalinic acid

Science of the Total Environment

Volumn 450-451, Issue , 2013, Pages 242-249

  Burgard, Daniel A ^a   Fuller, Rick ^b   Becker, Brian ^a   Ferrell, Rebecca ^a   Dinglasan Panlilio, M J ^c  

^a UNIVERSITY OF PUGET SOUND   (United States)

^b Environmental Services   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Amphetamine; College use; Ritalinic acid; Sewage analysis; Study drugs; Wastewater epidemiology

Indexed keywords

DISEASES; DRUG PRODUCTS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHASE SEPARATION; STUDENTS; SURVEYS;

AMPHETAMINE; ATTENTION DEFICIT HYPERACTIVITY DISORDER; COLLEGE CAMPUS; COLLEGE-USE; HIGH STRESS; LOWER STRESS; RITALINIC ACID; STUDY DRUG; SURVEY DATA; WASTEWATER EPIDEMIOLOGY;

SEWAGE ANALYSIS;

AMPHETAMINE; DRUG METABOLITE; METHYLPHENIDATE; NON PRESCRIPTION DRUG; RITALINIC ACID;

DRUG; EPIDEMIOLOGY; METABOLITE; SEWAGE; UNIVERSITY SECTOR; WASTEWATER;

ARTICLE; ATTENTION DEFICIT DISORDER; COLLEGE; DRUG MISUSE; FEMALE; HUMAN; INFORMATION PROCESSING; LIQUID CHROMATOGRAPHY; MALE; PRESCRIPTION; PRIORITY JOURNAL; SCHOOL STRESS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; WASTE WATER;

UNITED STATES;

EID: 84875232913     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2013.02.020     Document Type: Article

References (45)

1. Adderall Prescribing Information, Shire US Inc., revised August 2011. Available at, [accessed October 16, 2012]. http://www.adderallxr.com/.
2. Babcock Q., Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health 2000, 49:143-145.
3. Barr D.B., Wilder L.C., Caudill S.P., Gonzalez A.J., Needham L.L., Pirkle J.L. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005, 113:192-200.
4. Batt A.L., Kostich M.S., Lazorchak J.M. Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS. Anal Chem 2008, 80:5021-5030.
5. Brewer A.J., Ort C., Banta-Green C.J., Berset J.D., Field J.A. Normalized diurnal and between-day trends in illicit and legal drug loads that account for changes in population. Environ Sci Technol 2012, 46:8305-8314.
6. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D., Zuccato E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ Sci Technol 2006, 40:357-363.
7. Castiglioni S., Zuccato E., Crisci E., Chiabrando C., Fanelli R., Bagnati R. Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography-tandem mass spectrometry. Anal Chem 2006, 78:8421-8429.
8. Illicit drugs in the environment 2011, John Wiley & Sons, Inc., Hoboken, NJ, USA, [January 18]. S. Castiglioni, E. Zuccato, R. Fanelli (Eds.).
9. Castiglioni S., Bijlsma L., Covaci A., Emke E., Hernández F., Reid M., et al. Evaluation of uncertainties associated with the determination of community drug use through the measurement of sewage drug biomarkers. Environ Sci Technol 2013, 47:1452-1460.
10. Chiaia A.C., Banta-Green C., Field J. Eliminating solid phase extraction with large-volume injection LC/MS/MS: analysis of illicit and legal drugs and human urine indicators in US wastewaters. Environ Sci Technol 2008, 42:8841-8848.
11. Concerta Prescribing Information, Janssen Pharmaceuticals Inc., revised March 2012. Available at, [accessed October 16, 2012]. http://www.concerta.net/adult/prescribing-information.html.
12. Daughton C.G., Ruhoy I.S. Environmental footprint of pharmaceuticals: the significance of factors beyond direct excretion to sewers. Environ Toxicol Chem 2009, 28:2495-2521.
13. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 1999, 907-938.
14. Farah M.J., Illes J., Cook-Deegan R., Gardner H., Kandel E., King P., et al. Neurocognitive enhancement: what can we do and what should we do?. Nat Rev Neurosci 2004, 5:421-425.
15. Focalin Prescribing Information, Novartis Pharmaceutical Corporation, revised May 2012. Available at, [accessed October 16, 2012]. http://www.pharma.us.novartis.com/product/pi/pdf/focalin.pdf.
16. Gros M., Petrović M., Barceló D. Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. Anal Chem 2009, 81:898-912.
17. Hall W., Prichard J., Kirkbride P., Bruno R., Thai P.K., Gartner C., et al. An analysis of ethical issues in using wastewater analysis to monitor illicit drug use. Addiction 2012, 107:1767-1773.
18. Harman C., Reid M., Thomas K.V. Concerning the viewpoint; "An anti-doping sampling strategy utilizing the sewerage systems of sport villages". Environ Sci Technol 2011, 45:4191. [author reply 4192].
19. Jiménez C., De la Torre R., Ventura M., Segura J., Ventura R. Stability studies of amphetamine and ephedrine derivatives in urine. J Chromatogr B Analyt Technol Biomed Life Sci 2006, 843:84-93.
20. Johnson J. College administrators worry that use of prescription stimulants is increasing 2011, November 28, The Washington Post, [sec. Local].
21. Johnston L.D. Monitoring the future: national survey results on drug use, 1975-2008. College students and adults ages 2010, vol. II:19-50. DIANE Publishing.
22. Jones-Lepp T.L., Alvarez D.A., Petty J.D., Huckins J.N. Polar organic chemical integrative sampling and liquid chromatography electrospray/ion-trap mass spectrometry for assessing selected prescription and illicit drugs in treated sewage effluents. Arch Environ Contam Toxicol 2004, 47:427-439.
23. Kasprzyk-Hordern B., Baker D.R. Estimation of community-wide drugs use via stereoselective profiling of sewage. Sci Total Environ 2012, 423:142-150.
24. Katsoyiannis A., Jones K.C. An anti-doping sampling strategy utilizing the sewerage systems of sport villages. Environ Sci Technol 2011, 45:362-363.
25. Kaye S., Darke S. The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?. Addiction 2012, 107:467-477.
26. Khan U., Nicell J.A. Sewer epidemiology mass balances for assessing the illicit use of methamphetamine, amphetamine and tetrahydrocannabinol. Sci Total Environ 2012, 421-422:144-162.
27. Krishnan S.M., Pennick M., Stark J.G. Metabolism, distribution and elimination of lisdexamfetamine dimesylate: open-label, single-centre, phase I study in healthy adult volunteers. Clin Drug Investig 2008, 28:745-755.
28. Letzel M., Weiss K., Schüssler W., Sengl M. Occurrence and fate of the human pharmaceutical metabolite ritalinic acid in the aquatic system. Chemosphere 2010, 81:1416-1422.
29. Mathieu C., Rieckermann Jörg, Berset J.D., Schürch S., Brenneisen R. Assessment of total uncertainty in cocaine and benzoylecgonine wastewater load measurements. Water Res 2011, 45:6650-6660.
30. McCabe S.E., Knight J.R., Teter C.J., Wechsler H. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 2005, 100:96-106.
31. Ort C., Lawrence M.G., Reungoat J., Mueller J.F. Sampling for PPCPs in wastewater systems: comparison of different sampling modes and optimization strategies. Environ Sci Technol 2010, 44:6289-6296.
32. Ort C., Lawrence M.G., Rieckermann Jörg, Joss A. Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review. Environ Sci Technol 2010, 44:6024-6035.
33. Panawennage D., Castiglioni S., Zuccato E., Davoli E., Paul Chiarelli M. Measurement of illicit drug consumption in small populations: prognosis for noninvasive drug testing of student populations. Illicit drugs in the environment 2011, 321-331. John Wiley & Sons, Inc., Hoboken, NJ, USA, [January 18]. S. Castiglioni, E. Zuccato, R. Fanelli (Eds.).
34. Ritalin and Ritalin-SR Prescribing Information, Novartis Pharmaceutical Corporation, revised April 2007. Available at:, [accessed October 16, 2012]. http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/010187s069,018029s040,021284s011lbl.pdf.
35. Schröder H., Gebhardt W., Thevis M. Anabolic, doping, and lifestyle drugs, and selected metabolites in wastewater - detection, quantification, and behaviour monitored by high-resolution MS and MS n before and after sewage treatment. Anal Bioanal Chem 2010, 398:1207-1229.
36. Shillington A.M., Reed M.B., Lange J.E., Clapp J.D., Henry S. College undergraduate Ritalin abusers in southwestern California: protective and risk factors. J Drug Issues 2006, 36:999.
37. Smith-Palmer T. Separation methods applicable to urinary creatine and creatinine. J Chromatogr B 2002, 781:93-106.
38. Talbot M. Brain gain. The New Yorker. April 27, 2009.
39. Thomas K.V., Bijlsma L., Castiglioni S., Covaci A., Emke E., Grabic R., et al. Comparing illicit drug use in 19 European cities through sewage analysis. Sci Total Environ 2012, 432:432-439.
40. Trudeau M. More students turning illegally to "Smart" drugs: NPR. NPR.org February 5, [Available at]. http://www.npr.org/templates/story/story.php?storyId=100254163.
41. Van Nuijs A.L.N., Castiglioni S., Tarcomnicu I., Postigo C., De Alda M.L., Neels H., et al. Illicit drug consumption estimations derived from wastewater analysis: a critical review. Sci Total Environ 2011, 409:3564-3577.
42. Van Nuijs A.L.N., Abdellati K., Bervoets L., Blust R., Jorens P.G., Neels H., et al. The stability of illicit drugs and metabolites in wastewater, an important issue for sewage epidemiology?. J Hazard Mater 2012, 239-240:19-23.
43. Vyvanse Prescribing Information, Shire US Inc., revised January 2012. Available at:, [accessed October 16, 2012]. http://pi.shirecontent.com/PI/PDFs/Vyvanse_USA_ENG.pdf.
44. Williams R.J., Goodale L.A., Shay-Fiddler M.A., Gloster S.P., Chang S.Y. Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents. Am J Addict 2004, 13:381-389.
45. Zuccato E., Chiabrando C., Castiglioni S., Calamari D., Bagnati R., Schiarea S., et al. Cocaine in surface waters: a new evidence-based tool to monitor community drug abuse. Environ Health-Glob 2005, 4:10-1186.